R. M. Schaaper, T. A. Kunkel and L. A. Loeb, “Infidelity of DNA Synthesis Associated with Bypass of Apurinic Sites,” Proceedings of the National Academy of Sciences of the United States, Vol. 80, No. 2, 1983, pp. 487-491. doi:10.1073/pnas.80.2.487
 D. M. Wilson and D. Barsky, “The Major Human Abasic Endonuclease: Formation, Consequences and Repair of Abasic Lesions in DNA,” Mutation Research, Vol. 485, No. 4, 2001, pp. 283-307. doi:10.1016/S0921-8777(01)00063-5
 B. Muller-Hubenthal, M. Azemar, D. Lorenzen, M. Huber, M. A. Freudenberg, et al., “Tumor Biology: Tumour- Associated Inflammation versus Antitumor Immunity,” Anticancer Research, Vol. 29, No. 11, 2009, pp. 4795- 4806.
 M. H. Han, W. K. Yon, H. Lee, et al., “Topical Application of Silymarin Reduces Chemical-Induced Irritant Contact Dermatitis in BALB/c Mice,” International Immunopharmacology, Vol. 7, No. 13, 2007, pp. 1651-1658. doi:10.1016/j.intimp.2007.08.019
 P. C. Taylor, A. M. Peters, E. Paleolog, et al., “Reduction of Chemokine Levels and Leukocyte Traffic to Joints by Tumor Necrosis Factor Alpha Blockade in Patients with Rheumatoid Arthritis,” Arthritis & Rheumatism, Vol. 43, No. 1, 2000, pp. 38-47. doi:10.1002/1529-0131(200001)43:1<38::AID-ANR6>3.0.CO;2-L
 M. Tucci, C. Quatraro, M. A. Frassanito and F. Silvestris, “Deregulated Expression of Monocyte Chemoattractant Protein-1 (MCP-1) in Arterial Hypertension: Role of Endothelial Inflammation and Atheromasia,” Journal of Hypertension, Vol. 24, 2006, pp. 1307-1318. doi:10.1097/01.hjh.0000234111.31239.c3
 M. O’Hayre, C. L. Salanga, T. M. Handel and S. J. Allen, “Chemokines and Cancer: Migration, Intracellular Signaling and Intercellular Communication in the Microenvironment,” Biochemical Journal, Vol. 409, No. 3, 2008, pp. 635-649. doi:10.1042/BJ20071493
 J. Zhang, L. Chen, M. Xiao, et al., “FSP1+ Fibroblasts Promote Skin Carcinogenesis by Maintaining MCP-1 Mediated Macrophage Infiltration and Chronic Inflammation,” American Journal of Pathology, Vol. 178, No. 1, 2011, pp. 382-390. doi:10.1016/j.ajpath.2010.11.017
 A. Kapp, G. Zeck-Kapp, W. Czech and E. Schopf, “The Chemokine RANTES is More than a Chemoattractant: Characterization of Its Effect on Human Eosinophil Oxidative Metabolism and Morphology in Comparison with IL-5 and GM-CSF,” Journal of Investigative Dermatology, Vol. 102, No. 6, 1994, pp. 906-914. doi:10.1111/1523-1747.ep12383399
 S. Kakolyris, L. Kaklamanis, A. Giatromanolaki, M. Koukourakis, S. I. D. Hickson, et al., “Expression and Subcellular Localization of Human AP Endonuclease 1 (HAP1/Ref-1) Protein: A Basis for Its Role in Human Disease,” Histopath, Vol. 33, No. 6, 1998, pp. 561-569. doi:10.1046/j.1365-2559.1998.00541.x
 Y. Xu, D. H. Moore, J. Broshears, L. Liu, T. M. Wilson, et al., “The Apurinic/Apyrimidinic Endonuclease (APE/ Ref-1) DNA Repair Enzyme Is Elevated in Pre-Malignant and Malignant Cervical Cancer,” Anticancer Research, Vol. 17, No. 5B, 1997, pp. 3713-3719.
 D. H. Moore, H. Michael, R. Tritt, S. H. Parsons and M. R. Kelley, “Alterations in the Expression of the DNA Repair/Redox Enzyme APE/Ref-1 in Epithelial Ovarian Cancers,” Clinical Cancer Research, Vol. 6, No. 2, 2000, pp. 602-609.
 K. Ando, S. Hirao, Y. Kabe, Y. Ogura, I. Sato, Y. Yamaguchi, T. Wada and H. Handa, “A New APE1/Ref-1- Dependent Pathway Leading to Reduction of NF-Kappab and AP-1, and Activation of Their DNA-Binding Activity,” Nucleic Acids Research, Vol. 36, No. 13, 2008, pp. 4327-4336. doi:10.1093/nar/gkn416
 J. Liu, X. Gu, D. Robbins, G. Li, R. Shi, et al., “Protandim, a Fundamentally New Antioxidant Approach in Chemoprevention Using mouse Two-Stage Skin Carcinogenesis as a Model,” PLoS One, Vol. 4, No. 4, 2009, p. e5284. doi:10.1371/journal.pone.0005284
 Y. Zhao, L. Chaiswing, T. D. Oberley, I. Batinic-Harberle, W. St. Clair, et al., “A Mechanism-Based Antioxidant Approach for the Reduction of Skin Carcinogenesis,” Cancer Research, Vol. 65, No. 4, 2005, pp. 1401-1405. doi:10.1158/0008-5472.CAN-04-3334
 Y. Zhao, Y. Xue, T. D. Oberley, K. K. Kiningham, S. M. Lin, et al., “Overexpression of Manganese Superoxide Dismutase Suppresses Tumor Formation by Modulation of Activator Protein-1 Signaling in a Multistage Skin Carcinogenesis Model,” Cancer Research, Vol. 61, No. 16, 2001, pp. 6082-6088.
 Y. Zhao, K. K. Kiningham, S. M. Lin and D. K. St. Clair, “Overexpression of MnSOD Protects Murine Fibrosarcoma Cells (FSa-II) from Apoptosis and Promotes a Differentiation Program upon Treatment with 5-Azacytidine: Involvement of MAPK and NFkappaB Pathways,” Antioxidants & Redox Signaling, Vol. 3, No. 3, 2001, pp. 375-386. doi:10.1089/15230860152409022
 S. Grosch, G. Fritz and B. Kaina, “Apurinic Endonuclease (Ref-1) Is Induced in Mammalian Cells by Oxidative Stress and Is Involved in Clastogenic Adaptation,” Cancer Research, Vol. 58, No. 19, 1998, pp. 4410-4416.
 C. V. Ramana, I. Boldogh, T. Izumi and S. Mitra, “Activation of Apurinic/Apyrimidinic Endonuclease in Human Cells by Reactive Oxygen Species and Its Correlation with Their Adaptive Response to Genotoxicity of Free Radicals,” Proceedings of the National Academy of Sciences of United States, Vol. 95, No. 9, 1998, pp. 5061- 5066. doi:10.1073/pnas.95.9.5061
 A. Unnikrishnan, J. J. Raffoul, H. V. Patel, T. M. Prychitko, N. Anyangwe, et al., “Oxidative Stress Alters Base Excision Repair Pathway and Increases Apoptotic Response in Apurinic/Apyrimidinic Endonuclease 1/Redox Factor-1 Haploinsufficient Mice,” Free Radical Biology & Medicine, Vol. 46, No. 11, 2009, pp. 1488-1499.
 J. L. Hall, X. Wang, V. Adamson, Y. Zhao and G. H. Gibbons, “Overexpression of Ref-1 Inhibits Hypoxia and Tumor Necrosis Factor-Induced Endothelial Cell Apoptosis through Nuclear Factor-κB-Independent and -Dependent Pathways,” Circulation Research, Vol. 88, 2001, pp. 1247-1253. doi:10.1161/hh1201.091796
 M. Z. Hadi, M. A. Coleman, K. Fidelis, H. W. Mohrenweiser and D. M. Wilson III, “Functional characterization of Ape1 variants identified in the human population,” Nucleic Acids Research, Vol. 28, No. 20, 2000, pp. 3871- 3879. doi:10.1093/nar/28.20.3871